MYX 0.60% $5.01 mayne pharma group limited

Ann: Preliminary Final Report, page-2

  1. 296 Posts.
    lightbulb Created with Sketch. 2
    Sounds solid to me!

    • Revenue of $572.6m, an increase of 114% on FY16
    • Underlying EBITDA of $206.5m, up 133% on FY16
    • Reported EBITDA of $204.0m, up 165% on FY16
    • Reported net profit after tax was $88.6m, up 137% on FY16
    • Basic earnings per share of 6.2c, up 30% on FY16
    • Positive operating cash flow in 2H17 of $51.9m
    Last edited by EckQuity: 25/08/17
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$5.01
Change
-0.030(0.60%)
Mkt cap ! $426.2M
Open High Low Value Volume
$5.02 $5.09 $4.95 $846.7K 168.9K

Buyers (Bids)

No. Vol. Price($)
1 3251 $4.99
 

Sellers (Offers)

Price($) Vol. No.
$5.04 832 1
View Market Depth
Last trade - 16.10pm 03/06/2024 (20 minute delay) ?
Last
$5.00
  Change
-0.030 ( 0.93 %)
Open High Low Volume
$5.02 $5.09 $4.95 32681
Last updated 15.59pm 03/06/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.